ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension

ClinicalTrials.gov ID: NCT01788358

Public ClinicalTrials.gov record NCT01788358. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 13, 2026, 6:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Open-Label, Long-Term Safety and Efficacy Study of the Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Adult Subjects With Moderate to Severe Essential Hypertension

Study identification

NCT ID
NCT01788358
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
508 participants

Conditions and interventions

Conditions

Interventions

  • Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 13, 2013
Primary completion
Apr 30, 2014
Completion
Apr 30, 2014
Last update posted
Oct 23, 2017

2013 – 2014

United States locations

U.S. sites
39
U.S. states
21
U.S. cities
36
Facility City State ZIP Site status
Not listed Foley Alabama 36535
Not listed Carmichael California 95608
Not listed Los Angeles California 90057
Not listed Spring Valley California 91978
Not listed Milford Connecticut 06460
Not listed Coral Gables Florida 33114-4192
Not listed Hallandale Florida 33009
Not listed Hollywood Florida 33083
Not listed Jacksonville Florida 32216
Not listed Jupiter Florida 33458
Not listed Tampa Florida 33606
Not listed Atlanta Georgia 30338
Not listed Valparaiso Indiana 46383
Not listed Newton Kansas 67114
Not listed Wichita Kansas 67205
Not listed Lexington Kentucky 40504
Not listed New Orleans Louisiana 70119
Not listed Auburn Maine 04240
Not listed Elkridge Maryland 21075
Not listed Brockton Massachusetts 02301
Not listed St Louis Missouri 63141
Not listed Shelby North Carolina 28150
Not listed Cincinnati Ohio 45224
Not listed Cincinnati Ohio 45245
Not listed Cincinnati Ohio 45246
Not listed Columbus Ohio 43213
Not listed Greenville South Carolina 29615
Not listed Mt. Pleasant South Carolina 29464
Not listed Rapid City South Dakota 57702
Not listed Nashville Tennessee 37203
Not listed New Tazewell Tennessee 37825
Not listed Beaumont Texas 77701
Not listed Bryan Texas 77802
Not listed Carrollton Texas 75010
Not listed Dallas Texas 75230
Not listed San Antonio Texas 78229
Not listed Salt Lake City Utah 84109
Not listed Salt Lake City Utah 84121
Not listed Kenosha Wisconsin 53142

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01788358, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 23, 2017 · Synced May 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01788358 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →